Articles by Jim Miller - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Jim Miller

Step Carefully into Foreign Affairs

As the pharmaceutical industry looks to emerging markets, corruption becomes an important issue.
Sep 1, 2009

As the pharmaceutical industry looks to emerging markets, corruption becomes an important issue.

Expansion plan

Sep 1, 2009

In the current slow growth environment, service providers are looking to tactical expansions, as well as more ambitious strategic service expansions.

Step Carefully into Foreign Affairs

As the pharmaceutical industry looks to emerging markets, corruption becomes an important issue.
Aug 2, 2009

As the pharmaceutical industry looks to emerging markets, corruption becomes an important issue.

Industry Outlook: Down But Not Out

The contract services industry may not be as robust in 2009 as it has been in previous years, but it's not as bad as many people think.
Aug 1, 2009

The contract services industry may not be as robust in 2009 as it has been in previous years, but it's not as bad as many people think.

Issue Extra: Executive Roundtable—The Future of Pharmaceutical CMC Outsourcing

A Q&A with Pfizer CentreSource, moderated by Jim Miller.
Aug 1, 2009

A Q&A with Pfizer CentreSource, moderated by Jim Miller.

The Future of Pharmaceutical CMC Outsourcing

A roundtable with pharma majors Pfizer and Johnson & Johnson, moderated by Jim Miller.
Aug 1, 2009

A roundtable with pharma majors Pfizer and Johnson & Johnson, moderated by Jim Miller.

Penny-Wise, Pound-Foolish

Pharma companies that sell redundant facilities could endanger their supply chains.
Jul 8, 2009

Pharma companies that sell redundant facilities could endanger their supply chains.

Limits to Growth?

A major CRO ventures further into proprietary drug development.
Jun 8, 2009

A major CRO ventures further into proprietary drug development.

Penny-Wise, Pound-Foolish

Pharma companies that sell redundant facilities could endanger their supply chains.
Jun 2, 2009

Pharma companies that sell redundant facilities could endanger their supply chains.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
32%
Breakthrough designations
8%
Protecting the supply chain
40%
Expedited reviews of drug submissions
8%
More stakeholder involvement
12%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
FindPharma Custom Search
Click here